Uridine and Pyrimidine Nucleotides in Cell Function

  • G. P. Connolly
Chapter
Part of the Purinergic and Pyrimidinergic Signalling book series (HEP, volume 151 / 1)

Abstract

The pyrimidine nucleosides, e.g. uridine and cytidine and the related nucleotides UDP and UTP, are endogenous cellular constituents that can modulate cell function at both the intra- and extra-cellular levels. Many disorders of pyrimidine metabolism are linked to altered cytidine and uracil metabolism, leading to systemic and neurological dysfunction. Pyrimidines can also alter cell activity, under physiological and pathological circumstances, via the activation of cell surface P2Y receptors (Communi and Boeynams 1997; Boarder and Webb, Chap. 4, this volume).

Keywords

Schizophrenia Porphyrin Prolactin Galactose Neuroblastoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agnati LF, Fuxe K, Eneroth P, Zini I, Harfstrand A, Grimaldi R, Zoli M (1986) Intravenous uridine treatment antagonizes hypoglycaemia-induced reduction in brain somatostatin-like immunoreactivity. Acta Physiol Scand 126: 525–531PubMedCrossRefGoogle Scholar
  2. Agnati LF, Fuxe K, Rugger M, Pich EM, Benfenati F, Volterra V, Ungerstedt U, Zini I (1989) Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidol. Neurochem Internat 15: 107–113CrossRefGoogle Scholar
  3. Becroft DM, Phillips LI, Simmonds A (1969) Hereditary orotic aciduria: long-term therapy with uridine and a trial of uracil. J Pediatrics 75: 885–891CrossRefGoogle Scholar
  4. Benzi G, Villa RF, Dossena M,Vercesi L, Gorini A, Pastoris 0 (1984) Cerebral endogenous substrate utilisation during the recovery period after profound hypoglycemia. J Neurosci Res 11: 437–450Google Scholar
  5. Berman P, Harley E (1984) Orotate uptake and metabolism by human erythrocytes. Advan Exper Med Biol 165: 367–371CrossRefGoogle Scholar
  6. Bernardini R, De Luca G, Marino D (1983) Effect of glutamine and nucleosides on prolactin secretion in the rat. Acta Europaea Fertilitatis 14: 341–344PubMedGoogle Scholar
  7. Bocharova LS, Gordon RY, Arkhipov VI (1992) Uridine uptake and RNA synthesis in the brain of torpid and awakened ground squirrels. Comp Biochem Physiol B 101: 189–192PubMedGoogle Scholar
  8. Boehm S, Huck S, Illes P, (1995) UTP- and ATP-triggered transmitter release from rat sympathetic neurones via separate receptors. Br J Pharmacol 116: 2341–2343PubMedCrossRefGoogle Scholar
  9. Bonavita V, Piccoli F, Savettieri G, Zito M (1975) Observations on the therapeutic usefulness of uridine in epilepsy ( Italian ). Acta Neurol 30: 30–34Google Scholar
  10. Bonavita V, Scarano E, Zito M (1962) The action of purine and pyrimidine nucleosides on the human brain as revealed by pentothal-activated EEG. Arch Int Pharmacodyn 138: 152–156PubMedGoogle Scholar
  11. Bonavita V, Bonasera N, Zito M, Scarano E (1963) Electrophysiological and neurochemical studies following injection of mono-nucleotides and their derivatives. J Neurochem 10: 155–164PubMedCrossRefGoogle Scholar
  12. Calabresi P, Falcone A, St Clair MH, Wiemann MC, Chu SH, Darnowski JW (1990) Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity. Blood 76: 2210–2215PubMedGoogle Scholar
  13. Chambers JK, Macdonald LE, Sarau HM, Ames RS, Freemann K, Foley JJ, Zhu Y, McLaughlin MM, Murdock P, McMillan L, Trill J, Swift A, Aiyar N, Taylor P,Vawter L, Naheed S, Szekeres P, Hervieu G, Scott C, Watson JM, Murphy AJ, Duzic E, Klein C, Bergsma DJ, Wilson S, Livi GP (2000) A G Protein-coupled Receptor for UDP-glucose. J Biol Chem 275: 10767–10771Google Scholar
  14. Codacci-Pisanelli G, Kralovanszky J, van der Wilt CL, Noordhuis P, Colofiore JR, Martin DS, Franchi F, Peters GJ (1997) Modulation of 5-fluorouracil in mice using uridine diphosphoglucose. Clin Cancer Res 3: 309–315PubMedGoogle Scholar
  15. Coltorti M (1975) Influence of UDPG, glutathione and vitamin B 12 therapy on various liver function indices in patients with liver cirrhosis. (Italian) Clinica Terapeutica 72: 323–335PubMedGoogle Scholar
  16. Connolly GP (1994) Neurobiological aspects of pyrimidines. Pathways Pyrimidines 2: 37–44Google Scholar
  17. Connolly GP, Abbott NJ, Demaine C, Duley JA (1997) Investigation of receptors responsive to pyrimidines. Trends Pharmacol Sci 18: 413–414PubMedGoogle Scholar
  18. Connolly GP, Demaine C, Duley JA (1998) Ecto-nucleotidases in isolated intact rat vagi, nodose ganglia, and superior cervical ganglia. Adv Exper Med Bio1431: 769–776Google Scholar
  19. Connolly GP, Demaine C, Duley JA (1998) Ecto-nucleotidase activity of cultured rat superior cervical ganglia. Cell Mol Biol Let 4: 351Google Scholar
  20. Connolly GP, Harrison PJ, Stone TW (1993) Action of purine and pyrimidine nucleotides on the rat superior cervical ganglion. Br J Pharmacol 110: 1297–1304PubMedCrossRefGoogle Scholar
  21. Connolly GP, Harrison PJ (1995) Structure-activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion. Br J Pharmacol 116: 2764–2770PubMedCrossRefGoogle Scholar
  22. Connolly GP, Simmonds HA, Duley JA (1996) Pyrimidines and CNS regulation. Trends Pharmacol Sci 17: 106–107PubMedCrossRefGoogle Scholar
  23. Dawson DM (1968) Enzymic conversion of uridine nucleotide to cytidine nucleotide by rat brain. J Neurochem 15: 31–34PubMedCrossRefGoogle Scholar
  24. Dierich A, Wintzerith M, Sarlieve L, Mandel P (1980) Biosynthesis pathways of nucleotides in different nerve cell cultures. J Neurochem 34: 1126–1129PubMedCrossRefGoogle Scholar
  25. Drago G, Casetti P, Nicosia F (1967) Uridine and cytidine in the treatment of hepatic coma. Preliminary note. ( Italian) Osp Ital Chir 17: 651–657Google Scholar
  26. Drago F, D’Agata V, Valerio C, Spadaro F, Raffaele R, Nardo L. Grassi M, Freni V (1990) Memory deficits of aged male rats can be improved by pyrimidine nucleosides and n-acetyl-glutamine. Clin Neuropharm 13: 290–296Google Scholar
  27. el Kouni MH, Naguib FN, Park KS, Cha S, Darnowski JW, Soong SJ (1990) Circadian rhythm of hepatic uridine phosphorylase activity and plasma concentration of uridine in mice. Biochem Pharmac 40: 2479–2485CrossRefGoogle Scholar
  28. Foresta C, Rossato M, Chiozzi P, Di Virgilio F (1996) Mechanism of human sperm activation by extracellular ATP. Am J Physiol 270: C1709 - C1714PubMedGoogle Scholar
  29. Hogans AF, Guroff G, Udenfriend S (1971) Studies on the origin of pyrimidines for biosynthesis of neural RNA in the rat. J Neurochemistry 18: 1699–1710CrossRefGoogle Scholar
  30. Falcone A, Darnowski JW, Ruprecht RM, Chu SH, Brunetti I, Calabresi P (1990) Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice. Blood 76: 2216–2221PubMedGoogle Scholar
  31. Farabegoli C, Merlo Pich E, Cimino M, Agnati LF, Fuxe K (1988) Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours. Acta Physiol Scan 132: 209–216CrossRefGoogle Scholar
  32. Gallai V, Mazzzotta G, Montesi S, Sarchielli P, Del Gatto F (1992) Effects of uridine in the treatment of diabetic neuropathy: an electrophysiological study. Acta Neurol Scand 86: 3–7PubMedCrossRefGoogle Scholar
  33. Geiger A, Yamasaki S (1956) Cytidine and uridine requirement of the brain. J Neurochem 1: 93–100PubMedCrossRefGoogle Scholar
  34. Gerrits GP, Monnens LA, De Abreu RA, Schroder CH,Trijbels JM, Gabreels FJ (1991) Disturbances of cerebral purine and pyrimidine metabolism in young children with chronic renal failure. Nephron 58: 310–314Google Scholar
  35. Guarneri P, Piccoli F, Mocciaro C, Guarneri R (1983) Interaction of uridine with GABA binding sites in cerebellar membranes of the rat. Neurochem Res 8: 1537–1545PubMedCrossRefGoogle Scholar
  36. Guarneri P, Guarneri R, La Bella V, Piccoli F (1985) Interaction between uridine and GABA-mediated inhibitory transmission: studies in vivo and in vitro. Epilepsia 26: 666–671PubMedCrossRefGoogle Scholar
  37. Guroff G, Brodsky M (1971) Enzymes of nucleic acid metabolism in the brains of young and adult rats. J Neurochem 18: 2077–2084PubMedCrossRefGoogle Scholar
  38. Goetz U, Da Prada M, Pletscher A (1971) Adenine-, guanine-and uridine-5’-phosphonucleotides in blood platelets and storage organelles of various species. J Pharmacol Exp Ther 178: 210–215PubMedGoogle Scholar
  39. Gonzalez FJ, Fernandez-Salguero P (1995) Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency. Trends Pharmacol Sci 16: 325–327PubMedCrossRefGoogle Scholar
  40. Harden TK, Lazarowski ER, Boucher RC (1997) Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity. Trends Pharmacol Sci 18: 43–46PubMedCrossRefGoogle Scholar
  41. Honda K, Komoda Y, Nishida S, Nagasaki H, Higashi A, Uchizono K, Inoue S (1984) Uridine as an active component of sleep-promoting substance: its effects on nocturnal sleep in rats. Neurosci Res 1: 243–252PubMedCrossRefGoogle Scholar
  42. Hussain SP, Alexander N, Duley JA, Connolly GP (1999) Abnormal intracellular signalling in skin fibroblasts from LNS patients and HGPRT deficient neuroblastoma. Cell Mol Biol Let 4: 375–376Google Scholar
  43. Kardos J, Kovacs I, Szarics E, Kovacs R, Skuban N, Nyitrai G, Dobolyi A, Juhasz G (1999) Uridine activates fast transmembrane Ca’ ion fluxes in rat brain homogenates. Neuroreport 10: 1577–1582PubMedCrossRefGoogle Scholar
  44. Karkishchenko NN, Makliakov IuS, Stradomskii BV (1990) Pyrimidine derivatives: their psychotropic properties and the molecular mechanisms of their central action ( Russian ). Farmakologiia i Toksikologiia 53: 67–72Google Scholar
  45. Keilbaugh SA, Hobbs GA, Simpson MV (1993) Anti-human immunodeficiency virus type 1 therapy and peripheral neuropathy: prevention of 2′,3′-dideoxycytidine toxicity in PC12 cells, a neuronal model, by uridine and pyruvate. Mol Pharmacol 44: 702–706PubMedGoogle Scholar
  46. Kelsen DP, Martin D, O’Neil J, Schwartz G, Saltz L, Sung MT, von Borstel R, Bertino J (1997) Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer. J Clinical Oncology 15: 1511–1517Google Scholar
  47. Kihara H (1967) Pseudouridinuria in mentally defective siblings. Am J Ment Defic 71: 593–596PubMedGoogle Scholar
  48. Kimura T, Yamamoto I, Watanabe K, Tateoka Y, Ho IK (1991) In vivo and in vitro metabolic studies of N3-benzyluridine which exhibits hypnotic activity in mice. Res Corn Chem Path Pharmac 71: 27–48Google Scholar
  49. Kimura T, Kuze J, Watanabe K, Kondo S, Ho IK, Yamamoto I (1996) N3-phenacyluridine, a novel hypnotic compound, interacts with the benzodiazepine receptor. Eur J Pharmacol 311: 265–269PubMedCrossRefGoogle Scholar
  50. Kirkman HN Jr (1992) Erythrocytic uridine diphosphate galactose in galactosaemia. J Inher Meta Dis 15: 4–16CrossRefGoogle Scholar
  51. Knowles MR, Clarke LL, Boucher RC (1991) Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. New Engl J Med 325: 533–538PubMedCrossRefGoogle Scholar
  52. Kovacs Z, Dobolyi A, Szikra T, Palkovits M, Juhasz G (1999) Uneven regional distribution of nucleotide metabolism in human brain. Neurobiology (Budapest) 6: 315–321Google Scholar
  53. Kunapuli SP, Daniel JL (1998) P2 receptor subtypes in the cardiovascular system. Biochem. J 336: 513–523PubMedGoogle Scholar
  54. Leyva A, van Groeningen CJ, Kraal I, Gall H, Peters GJ, Lankelma J, Pinedo HM (1984) Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity. Cancer Res 44: 5928–5933PubMedGoogle Scholar
  55. Mandel P, Edel-Harth S (1966) Free nucleotides in the rat brain during post-natal development. J Neurochem 13: 591–595PubMedCrossRefGoogle Scholar
  56. Mandel P, Edel S, Poirel G (1966) Free nucleotides in rabbit and guinea pig brain. J Neurochem 13: 885–886PubMedCrossRefGoogle Scholar
  57. Minelli A, Moroni M, Mezzasoma I (1997) Human seminal plasma soluble 5′-nucleotidase: regulatory aspects of the dephosphorylation of nucleoside 5′-monophosphates. Biochem Mol Med 61: 95–101PubMedCrossRefGoogle Scholar
  58. Myers CS, Napolitano M, Fisher H, Wagner GC (1993) Uridine and stimulant-induced motor activity. Proc Soc Exp Biol Med 204: 49–53PubMedGoogle Scholar
  59. Myers CS, Wagner GC, Fisher H (1995) Uridine reduces rotation induced by L-dopa and methamphetamine in 6-OHDA-treated rats. Pharmacol Biochem Behav 52: 749–753PubMedCrossRefGoogle Scholar
  60. Ng WG, Xu YK, Kaufman FR, Donnell GN (1989) Deficit of uridine diphosphate galactose in galactosaemia. J Inher Metab Dise 12: 257–266CrossRefGoogle Scholar
  61. Olivier KN, Bennett WD, Hohneker KW, Zeman KL, Edwards LJ, Boucher RC, Knowles MR (1996) Acute safety and effects on mucociliary clearance of aerosolized uridine 5’-triphosphate +I amiloride in normal human adults. Am J Resp Critical Care Med 154: 217–223CrossRefGoogle Scholar
  62. Okolicsanyi L, Orlando R, Lirussi F, Naccarato R, Dal Brun G (1980a) Pharmacometabolic activity in chronic hepatopathies: influence of treatment with UDPG. (Italian) Clinica Terapeutica 93: 431–438Google Scholar
  63. Okolicsanyi L, Orlando R, Busnardo F, Naccarato R, Veller-Fornasa C, Polin R (1980b) Effectiveness of UDPG in the treatment of porphyria cutanea tarda. Preliminary findings. ( Italian) Clinica Terapeutica 94: 687–694Google Scholar
  64. Page T, Yu A, Fontanesi J, Nyhan WL (1997) Developmental disorder associated with increased cellular nucleotidase activity. Proc Nat Acad Sci 94: 11601–11606PubMedCrossRefGoogle Scholar
  65. Paglia DE, Valentine WN, Nakatani M, Rauth BJ (1983) Selective accumulation of cytosol CDP-choline as an isolated erythrocyte defect in chronic hemolysis. Proc Nat Acad Sci USA 80: 3081–3085PubMedCrossRefGoogle Scholar
  66. Parenti F (1992) Uridine associated with haloperidol in the treatment of schizophrenia: preliminary results. Clin Neuropharm 15: 369CrossRefGoogle Scholar
  67. Persson BE, Sjoman M, Niklasson F, Ronquist G (1991) Uridine, xanthine and urate concentrations in prostatic fluid and seminal plasma of patients with prostatitis. Euro Urology 19: 253–256Google Scholar
  68. Peters GJ, van Groeningen CJ, Laurensse EJ, Lankelma J, Leyva A, Pinedo HM (1987a) Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites. Cancer Chemother Pharmacol 20: 101–108PubMedCrossRefGoogle Scholar
  69. Peters GJ, van Groeningen CJ, Laurensse E, Kraal I, Leyva A, Lankelma J, Pinedo HM (1987b) Effect of pyrimidine nucleosides on body temperatures of man and rabbit in relation to pharmacokinetic data. Pharma Res 4: 113–119CrossRefGoogle Scholar
  70. Peters GJ, Van Dijk J, Nadal JC, Van Groeningen CJ, Lankelma J, Pinedo HM (1987c) Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. In Vivo 1: 113–117Google Scholar
  71. Popov N, Schmidt S, Matthies H (1984) Protective effect of uridine on Dgalactosamine-induced deficiency in brain uridine phosphates. Biomed Biochim Acta 43: 1399–1404PubMedGoogle Scholar
  72. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 60: 413–492.Google Scholar
  73. Rogers S, Segal S (1991) Modulation of rat tissue galactose-1-phosphate uridyltransferase by uridine and uridine triphosphate. Pediatr Res 30: 222–226PubMedCrossRefGoogle Scholar
  74. Ronquist G, Niklasson F (1984) Uridine, xanthine, and urate contents in human seminal plasma. Arch Androl 13: 63–70PubMedCrossRefGoogle Scholar
  75. Ronquist G, Stegmayr B, Niklasson F (1985) Sperm motility and interactions among seminal uridine, xanthine, urate, and ATPase in fertile and infertile men. Arch Androl 15: 21–27PubMedCrossRefGoogle Scholar
  76. Scriver CR, Beaudet AL, Sly WS, Valle D (eds ) (1995) The metabolic and molecular bases of inherited disease, vol2, 7th edn. McGraw-Hill, New York, chaps 49–55 Schmid-Elsaesser R, Zausinger S, Hungerhaber E, Baethmann A, Reulen HJ (1997)Google Scholar
  77. Scriver CR, Beaudet AL, Sly WS, Valle D (eds ) (1995) The metabolic and molecular bases of inherited disease, vol2, 7th edn. McGraw-Hill, New York, chaps 49–55 Schmid-Elsaesser R, Zausinger S, Hungerhaber E, Baethmann A, Reulen HJ (1997)Google Scholar
  78. Neuroprotective properties of a novel antioxidant (U-101033 E) with improved blood-brain barrier permeability in focal cerebral ischemia. Acta NeurochirurgicaSupplementum 70:176–178Google Scholar
  79. Seifert R, Schultz G (1989) Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Phramacol Sci 10: 365–369CrossRefGoogle Scholar
  80. Siggins G, Gruol D, Padjen A, Forman D (1978) Action of purine and pyrimidine mononucleotides on central and cultured sympathetic neurons. In: Ryall RW, Kelly JS (eds) Iontophoresis and transmitter mechanisms in the mammalian central nervous system. Elsevier, Amsterdam, pp 453–455Google Scholar
  81. Spector R (1985) Uridine transport and metabolism in the central nervous system. J Neurochem 45: 1411–1418PubMedCrossRefGoogle Scholar
  82. Stacey NC, Ma HY. Duley JA, Connolly GP (2000) Abnormalities in cellular adhesion of neuroblastoma and fibroblast models of Lesch Nyhan Syndrome. Neuroscience 98: 397–401PubMedCrossRefGoogle Scholar
  83. Tomlins AM, Foxall PJ, Lynch MJ, Parkinson J, Everett JR, Nicholson JK (1998) High resolution 1H NMR spectroscopic studies on dynamic biochemical processes in incubated human seminal fluid samples. Biochim Biophys Acta 1379: 367–380PubMedCrossRefGoogle Scholar
  84. Traut TW (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140: 1–22PubMedCrossRefGoogle Scholar
  85. Tremblay GC, Jimenez U, Crandall DE (1976) Pyrimidine biosynthesis and its regulation in the developing rat brain. J Neurochem 26: 57–64PubMedGoogle Scholar
  86. Usami M, Furuchi K, Ogino M, Kasahara H, Kanamaru T, Saitoh Y,Yokoyama H, Kano S (1996) The effect of a nucleotide-nucleoside solution on hepatic regeneration after partial hepatectomy in rats. Nutrition 12: 797–803Google Scholar
  87. Valentine WN, Fink K, Paglia DE, Harris SR, Adams WS (1974) Hereditary hemolytic anemia with human erythrocyte pyrimidine 5′-nucleotidase deficiency. J Clin Invest 54: 866–879PubMedCrossRefGoogle Scholar
  88. Van-Groeningen CJ, Leyva A, Kraal I, Peters GJ, Pinedo HM (1986) Clinical and pharmacokinetic studies of prolonged administration of high-dose uridine intended for rescue from 5-FU toxicity. Cancer Treat Rep 70: 745–750PubMedGoogle Scholar
  89. Watabe T (1996) Strategic proposals for predicting drug-drug interactions during new drug development: based on sixteen deaths caused by interactions of the new antiviral sorivudine with 5-fluorouracil prodrugs. J Tox Sci 21: 299–300CrossRefGoogle Scholar
  90. Williams, M, Jarvis MF (2000) Purinergic and pyrimidinergic receptors as potential drug targets. Biochem Pharmacol 59: 1173–1185PubMedCrossRefGoogle Scholar
  91. Wu WL, So SC, Sun YP, Chung YW, Grima J, Wong PY, Yan YC, Chan HC (1998). Functional expression of P2U receptors in rat spermatogenic cells: dual modulation of a Ca(2+)-activated K+ channel. Biochem Biophys Res Comm 248: 728–732PubMedCrossRefGoogle Scholar
  92. Xuma M, Turkington RW (1972) Hormonal regulation of uridine diphosphatase during spermatogenesis in the rat. Endocrinology 91: 415–422PubMedCrossRefGoogle Scholar
  93. Zimmerman H, Braun N (1999) Ecto-nucleotidases — molecular structures, catalytic properties, and functional roles in the nervous system. Prog Brain Res 120: 371–385CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • G. P. Connolly

There are no affiliations available

Personalised recommendations